As rmIL-33 administration induced microglia proliferation/recruitment with IL-1β overexpression, we next questioned whether IL-1 contributes to the maintenance of inflammation and the cognitive disorders induced by exogenous rmIL-33. The gene discussed is IL1B; the disease is cognitive disorder.